Norepinephrine in septic patients - Friend or foe?

Journal of Clinical Anesthesia

Volumn 15, Issue 2, 2003, Pages 154-158

  Theilmeier, Gregor ^a   Booke, Michael ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Main Taunus Kliniken   (Germany)

Author keywords

Downregulation; Norepinephrine; Sepsis

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; CATECHOLAMINE RECEPTOR; DOBUTAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN;

CLINICAL PRACTICE; DOWN REGULATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENTEROPATHY; HEMODYNAMICS; HUMAN; HYPOTENSION; KIDNEY DISEASE; LIVER DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SIDE EFFECT; VASCULAR DISEASE; VASOCONSTRICTION;

EID: 0037360352     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(02)00504-4     Document Type: Review

References (44)

1. Smulian H., Cuddy R.P., Eich R.H. Hemodynamic effects of pressor agents in septic and myocardial infarction shock. JAMA. 190:1964;188-192.
2. Revelly J.P., Liaudet L., Frascarolo P., Joseph J.M., Martinet O., Market M. Effects of norepinephrine on the distribution of intestinal blood flow and tissue adenosine triphosphate content in endotoxic shock. Crit Care Med. 28:2000;2500-2506.
3. Yang S., Zhou M., Chaudry I.H., Wang P. Norepinephrine-induced hepatocellular dysfunction in early sepsis is mediated by activation of alpha2-adrenoceptors. Am J Physiol Gastrointest Liver Physiol. 281:2001;G1014-1021.
4. Wang P., Tait S.M., Chaudry I.H. Sustained elevation of norepinephrine depresses hepatocellular function. Biochim Biophys Acta. 1535:2000;36-44.
5. Koo D.J., Chaudry I.H., Wang P. Mechanism of hepatocellular dysfunction during sepsis the role of gut-derived norepinephrine (review). Int J Mol Med. 5:2000;457-465.
6. Duranteau J., Sitbon P., Teboul J.L., et al. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med. 27:1999;893-900.
7. Chernow B., Roth B.L. Pharmacologic manipulation of the peripheral vasculature in shock clinical and experimental approaches. Circ Shock. 18:1986;141-155.
8. Michel M.C., Philipp T., Brodde O.E. Alpha- and beta-adrenoceptors in hypertension molecular biology and pharmacological studies. Pharmacol Toxicol. 70:(6 Pt 2):1992;S1-10.
9. Briegel J., Forst H., Haller M., et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock a prospective, randomized, double-blind, single-center study. Crit Care Med. 27:1999;723-732.
10. Landry DW, Levin heart rate, Gallant EM et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997;95:1122-5.
11. Bulger E.M., Maier R.V. Lipid mediators in the pathophysiology of critical illness. Crit Care Med. 28:(Suppl 4):2000;N27-36.
12. Bersten A.D., Hersch M., Cheung H., Rutledge F.S., Sibbald W.J. The effect of various sympathomimetics on the regional circulations in hyperdynamic sepsis. Surgery. 112:1992;549-561.
13. Pleiner J., Heere-Ress E., Langenberger H., et al. Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol. 22:2002;95-100.
14. Hwang T.L., Lau Y.T., Huang S.F., Chen M.F., Liu M.S. Changes of alpha 1-adrenergic receptors in human liver during intraabdominal sepsis. Hepatology. 20:1994;638-642.
15. Carcillo J.A., Litten R.Z., Roth B.L. Norepinephrine-induced phosphorylation of a 25 kd phosphoprotein in rat aorta is altered in intraperitoneal sepsis. Circ Shock. 28:1989;257-265.
16. Daveu C., Servy C., Dendane M., Marin P., Ducrocq C. Oxidation and nitration of catecholamines by nitrogen oxides derived from nitric oxide. Nitric Oxide. 1:1997;234-243.
17. Shintani F., Kinoshita T., Kanba S., et al. Bioactive 6-nitronorepinephrine identified in mammalian brain. J Biol Chem. 271:1996;13561-13565.
18. Macarthur H., Westfall T.C., Riley D.P., Misko T.P., Salvemini D. Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA. 97:2000;9753-9758.
19. Woodman O.L., Pannangpetch P. Enhancement of noradrenergic constriction of large coronary arteries by inhibition of nitric oxide synthesis in anaesthetized dogs. Br J Pharmacol. 112:1994;443-448.
20. Szabo C., Mitchell J.A., Thiemermann C., Vane J.R. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol. 108:1993;786-792.
21. Landin L., Lorente J.A., Renes E., Canas P., Jorge P., Liste D. Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis. Chest. 106:1994;250-256.
22. Meyer J., Booke M., Waurick R., Prien T., Van Aken H. Nitric oxide synthase inhibition restores vasopressor effects of norepinephrine in ovine hyperdynamic sepsis. Anesth Analg. 83:1996;1009-1013.
23. Kanagy N.L. Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension. Am J Physiol. 273:(6 Pt 2):1997;H2756-2764.
24. Hollenberg S.M., Piotrowski M.J., Parrillo J.E. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats. Am J Physiol. 272:(3 Pt 2):1997;R969-974.
25. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz. 3:1995;2-32.
26. Nasraway S.A. Jr. Sepsis research we must change course. Crit Care Med. 27:1999;427-430.
27. LeDoux D., Astiz M.E., Carpati C.M., Rackow E.C. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med. 28:2000;2729-2732.
28. Sielenkamper A.W., Meyer J., Kloppenburg H., Eicker K., Van Aken H. The effects of sepsis on gut mucosal blood flow in rats. Eur J Anaesthesiol. 18:2001;673-678.
29. Talmor M., Hydo L., Barie P.S. Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness effect of intensive care unit resuscitation. Arch Surg. 134:1999;81-87.
30. Liano F., Junco E., Pascual J., Madero R., Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int. 66:(Suppl):1998;S16-24.
31. Reinelt H., Radermacher P., Kiefer P., et al. Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med. 27:1999;325-331.
32. Martin C., Viviand X., Leone M., Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med. 28:2000;2758-2765.
33. Yamazaki T., Shimada Y., Taenaka N., Oshumi H., Takezawa J., Yoshiya I. Circulatory responses to afterloading with phenylephrine in hyperdynamic sepsis. Crit Care Med. 10:1982;432-435.
34. Ruokonen E., Takala J., Kari A., Saxen H., Mertsola J., Hansen E.J. Regional blood flow and oxygen transport in septic shock. Crit Care Med. 21:1993;1296-1303.
35. Dasta J.F. Norepinephrine in septic shock renewed interest in an old drug. DICP. 24:1990;153-156.
36. Desjars P., Pinaud M., Potel G., Tasseau F., Touze M.D. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med. 15:1987;134-137.
37. Meier-Hellmann A., Specht M., Hannemann L., Hassel H., Bredle D.L., Reinhart K. Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsis. Intensive Care Med. 22:1996;1354-1359.
38. Martin C., Papazian L., Perrin G., Saux P., Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest. 103:1993;1826-1831.
39. Rudis M.I., Basha M.A., Zarowitz B.J. Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med. 24:1996;525-537.
40. Marik P., Zaloga G. Prognostic value of cortisol response in septic shock. JAMA. 284:2000;308-309.
41. McBride W.T., Armstrong M.A., McBride S.J. Immunomodulation an important concept in modern anaesthesia. Anaesthesia. 51:1996;465-473.
42. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems the brain and the immune system. Pharmacol Rev. 52:2000;595-638.
43. Tang Y., Shankar R., Gamboa M., Desai S., Gamelli R.L., Jones S.B. Norepinephrine modulates myelopoiesis after experimental thermal injury with sepsis. Ann Surg. 233:2001;266-275.
44. Pastores S.M., Hasko G., Vizi E.S., Kvetan V. Cytokine production and its manipulation by vasoactive drugs. New Horiz. 4:1996;252-264.